TransMedics (TMDX) EPS (Diluted) Growth (1y) (2021 - 2026)
TransMedics (TMDX) EPS (Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -18.71% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.88% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 98.71% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 95.96% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -29.80% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 114.19% |
| 10 | TransMedics | 2.56 Bn | 2.10 Bn | 101.16 Mn | -68.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68.58% |
| Dec 31, 2025 | 481.53% |
| Sep 30, 2025 | 405.14% |
| Jun 30, 2025 | 148.89% |
| Mar 31, 2025 | 82.90% |
| Dec 31, 2024 | -1,415.86% |
| Sep 30, 2024 | 115.16% |
| Jun 30, 2024 | 1,223.49% |
| Mar 31, 2024 | 530.44% |
| Dec 31, 2023 | 127.00% |
| Sep 30, 2023 | -217.31% |
| Jun 30, 2023 | 92.53% |
| Mar 31, 2023 | 78.38% |
| Dec 31, 2022 | 50.98% |
| Sep 30, 2022 | 47.50% |
| Jun 30, 2022 | -6.61% |
| Mar 31, 2022 | -30.63% |
| Dec 31, 2021 | -79.09% |
| Sep 30, 2021 | -149.74% |
| Jun 30, 2021 | -6.05% |